disease therapeutics - Robuta Search

https://www.fvhospital.com/academic/scientific-conference-emerging-trends-in-cardiovascular-disease-therapeutics/ SCIENTIFIC CONFERENCE: EMERGING TRENDS IN CARDIOVASCULAR DISEASE THERAPEUTICS - FV Hospital Current cardiovascular treatment has evolved beyond traditional protocols, with significant advances in minimally invasive interventional techniques and scientific conference emerging trends cardiovascular disease fv hospital therapeutics https://www.grandviewresearch.com/industry-analysis/infectious-disease-therapeutics-market Infectious Disease Therapeutics Market | Industry Report 2030 Infectious disease therapeutics market size was at $243,409.1Mn in 2024, is projected to reach $283,908.2Mn by 2030, at a CAGR of 3.5% from 2025 to 2030. market industry report infectious disease therapeutics 2030 https://www.biocryst.com/ BioCryst® | A Pioneer in Rare Disease Therapeutics Apr 21, 2026 - We are BioCryst, a different kind of biotech company. Learn about our commitment to the rare disease patient community and discover career opportunities. rare disease pioneer therapeutics https://chiesirarediseases.com/ Chiesi Global Rare Diseases | A Rare Disease Therapeutics Company Chiesi Global Rare Diseases is a family-owned and run biopharmaceutical company with a commitment to providing transformative care to patients with rare... global rare disease therapeutics chiesi diseases company https://www.precedenceresearch.com/infectious-disease-therapeutics-market Infectious Disease Therapeutics Market Size to Hit USD 53.48 Billion by 2035 Nov 19, 2025 - The infectious disease therapeutics market size is calculated at USD 36.22 billion in 2025 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of... therapeutics market size infectious disease hit usd 53 48 billion https://beamtx.com/patients/disease-areas/ Disease Areas | Beam Therapeutics disease areas beam therapeutics https://www.ptcbio-en.se/ PTC Therapeutics | Pioneers in Rare Disease Treatments Oct 16, 2025 - Translating Science. Transforming Lives. rare disease treatments ptc therapeutics pioneers https://taytherapeutics.com/ Tay Therapeutics – Overcoming mutations, treating disease tay therapeutics overcoming mutations treating disease https://www.prnewswire.com/news-releases/neurocrine-to-acquire-soleno-therapeutics-expanding-its-endocrinology-and-rare-disease-portfolio-302734531.html Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio Apr 6, 2026 - VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative Therapy... soleno therapeutics rare disease neurocrine acquire expanding https://cogrx.com/pipeline/alzheimers-disease-moa/ Alzheimer’s Disease – Cognition Therapeutics, Inc. cognition therapeutics inc disease https://www.statnews.com/2026/04/13/spyre-ibd-drug-success-early-trial/ Spyre Therapeutics inflammatory bowel disease drug shows promise in trial Apr 13, 2026 - An inflammatory bowel disease treatment developed by Spyre Therapeutics sets the company up to compete with several large drugmakers. inflammatory bowel disease drug shows promise spyre therapeutics trial https://akerotx.com/ Akero Therapeutics | EFX for MASH | Metabolic Disease | Home Dec 5, 2025 - Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated steatohepatitis (MASH). akero therapeutics metabolic disease efx mash https://www.axsome.com/conditions/alzheimers-disease-agitation/ Alzheimer's Disease Agitation - Axsome Therapeutics Jan 27, 2025 - Agitation is reported in about 70% of people living with Alzheimer's disease (AD). Learn about Axsome's work in agitation in patients with AD, key facts and... axsome therapeutics alzheimer disease agitation https://www.bcm.edu/education/graduate-school-of-biomedical-sciences/degree-programs-and-certificates/development-disease-models-therapeutics-graduate-program Development, Disease Models & Therapeutics Graduate Program | BCM graduate program bcm disease models development therapeutics https://www.ptcbio.com/ PTC Therapeutics: Pioneering Rare Disease Treatments Apr 28, 2026 - Explore PTC Therapeutics' commitment to developing innovative treatments for rare diseases. rare disease treatments ptc therapeutics pioneering https://immunisbiomedical.com/home/ Therapeutics targeting age-related disease Jan 22, 2026 - Discover how Immunis, a private biotechnology company is developing new secretome products for the treatment of age-related immune dysfunction age related therapeutics targeting disease https://alector.com/ Alector Therapeutics for Neurodegenerative Disease Jun 9, 2025 - Alector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases. neurodegenerative disease alector therapeutics